467 related articles for article (PubMed ID: 32446698)
21. Sofosbuvir for COVID-19 infection: A potential candidate.
Gupta R; Dhamija P
Indian J Pharmacol; 2020; 52(3):232-233. PubMed ID: 32874010
[No Abstract] [Full Text] [Related]
22. Interferon-α2b spray inhalation did not shorten virus shedding time of SARS-CoV-2 in hospitalized patients: a preliminary matched case-control study.
Hao SR; Yan R; Zhang SY; Lian JS; Cai H; Zhang XL; Zheng L; Jia HY; Hu JH; Yu GD; Gu JQ; Ye CY; Jin CL; Lu YF; Xin JJ; Sheng JF; Yang YD
J Zhejiang Univ Sci B; 2020 Aug.; 21(8):628-636. PubMed ID: 32748578
[TBL] [Abstract][Full Text] [Related]
23. Audio Interview: New Data on Remdesivir in Covid-19.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2020 May; 382(22):e94. PubMed ID: 32459948
[No Abstract] [Full Text] [Related]
24. Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients.
Camprubí D; Almuedo-Riera A; Martí-Soler H; Soriano A; Hurtado JC; Subirà C; Grau-Pujol B; Krolewiecki A; Muñoz J
PLoS One; 2020; 15(11):e0242184. PubMed ID: 33175880
[TBL] [Abstract][Full Text] [Related]
25. Databases for the targeted COVID-19 therapeutics.
Wang Y; Li F; Zhang Y; Zhou Y; Tan Y; Chen Y; Zhu F
Br J Pharmacol; 2020 Nov; 177(21):4999-5001. PubMed ID: 32845521
[No Abstract] [Full Text] [Related]
26. [Not Available].
Nau JY
Rev Med Suisse; 2020 Mar; 16(687):606-607. PubMed ID: 32216186
[No Abstract] [Full Text] [Related]
27. [Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Should we target the virus, the cell or the disease?].
Nisole S; Saulnier A; Gatignol A
Virologie (Montrouge); 2020 Jun; 24(3):135-141. PubMed ID: 32648548
[No Abstract] [Full Text] [Related]
28. Clinical Characteristics and Outcomes of Coronavirus Disease 2019 Among Patients With Preexisting Liver Disease in the United States: A Multicenter Research Network Study.
Singh S; Khan A
Gastroenterology; 2020 Aug; 159(2):768-771.e3. PubMed ID: 32376408
[No Abstract] [Full Text] [Related]
29. Association of Nonsteroidal Anti-inflammatory Drug Use and Adverse Outcomes Among Patients Hospitalized With Influenza.
Lund LC; Reilev M; Hallas J; Kristensen KB; Thomsen RW; Christiansen CF; Sørensen HT; Johansen NB; Brun NC; Voldstedlund M; Støvring H; Thomsen MK; Christensen S; Pottegård A
JAMA Netw Open; 2020 Jul; 3(7):e2013880. PubMed ID: 32609352
[TBL] [Abstract][Full Text] [Related]
30. Outcome of non-invasive ventilation in COVID-19 critically ill patients: A Retrospective observational Study.
Mukhtar A; Lotfy A; Hasanin A; El-Hefnawy I; El Adawy A
Anaesth Crit Care Pain Med; 2020 Oct; 39(5):579-580. PubMed ID: 32736030
[No Abstract] [Full Text] [Related]
31. Impact of anticoagulation prior to COVID-19 infection: a propensity score-matched cohort study.
Tremblay D; van Gerwen M; Alsen M; Thibaud S; Kessler A; Venugopal S; Makki I; Qin Q; Dharmapuri S; Jun T; Bhalla S; Berwick S; Feld J; Mascarenhas J; Troy K; Cromwell C; Dunn A; Oh WK; Naymagon L
Blood; 2020 Jul; 136(1):144-147. PubMed ID: 32462179
[TBL] [Abstract][Full Text] [Related]
32. Remdesivir against COVID-19 and Other Viral Diseases.
Malin JJ; Suárez I; Priesner V; Fätkenheuer G; Rybniker J
Clin Microbiol Rev; 2020 Dec; 34(1):. PubMed ID: 33055231
[TBL] [Abstract][Full Text] [Related]
33. Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base.
Taccone FS; Gorham J; Vincent JL
Lancet Respir Med; 2020 Jun; 8(6):539-541. PubMed ID: 32304640
[No Abstract] [Full Text] [Related]
34. Asthma and COVID-19: Is asthma a risk factor for severe outcomes?
Johnston SL
Allergy; 2020 Jul; 75(7):1543-1545. PubMed ID: 32358994
[No Abstract] [Full Text] [Related]
35. Systemic Corticosteroids and Mortality in Severe and Critical COVID-19 Patients in Wuhan, China.
Wu J; Huang J; Zhu G; Liu Y; Xiao H; Zhou Q; Si X; Yi H; Wang C; Yang D; Chen S; Liu X; Liu Z; Wang Q; Lv Q; Huang Y; Yu Y; Guan X; Li Y; Nirantharakumar K; Cheng K; Peng S; Xiao H
J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32880390
[TBL] [Abstract][Full Text] [Related]
36. The potential role of nanomedicine on COVID-19 therapeutics.
Mainardes RM; Diedrich C
Ther Deliv; 2020 Jul; 11(7):411-414. PubMed ID: 32594863
[No Abstract] [Full Text] [Related]
37. East meets West in COVID-19 therapeutics.
Wang S; Zeng X; Wang Y; Zhao Y; Chen W; Chen YZ
Pharmacol Res; 2020 Sep; 159():105008. PubMed ID: 32531323
[No Abstract] [Full Text] [Related]
38. Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept.
Duret PM; Sebbag E; Mallick A; Gravier S; Spielmann L; Messer L
Ann Rheum Dis; 2020 Sep; 79(9):1251-1252. PubMed ID: 32354772
[No Abstract] [Full Text] [Related]
39. Effects of Corticosteroid Treatment for Non-Severe COVID-19 Pneumonia: A Propensity Score-Based Analysis.
Yuan M; Xu X; Xia D; Tao Z; Yin W; Tan W; Hu Y; Song C
Shock; 2020 Nov; 54(5):638-643. PubMed ID: 32496422
[TBL] [Abstract][Full Text] [Related]
40. Social media in the era of COVID-19.
Aggarwal NR; Alasnag M; Mamas MA
Open Heart; 2020 Sep; 7(2):. PubMed ID: 32994354
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
